Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Gastrointestinal Cancer Channel is supported with funding from Revolution Medicines (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

ESMO 2024 | The role of sex and gender in colorectal cancer treatment

Kathrin Heinrich, MD, Ludwig-Maximilians-Universität München, Munich, Germany, emphasizes the significance impact of sex and gender on colorectal cancer management. While sex refers to biological differences, gender encompasses the social and cultural influences on disease development and treatment. These factors affect diagnostic accuracy, treatment efficacy, and side effect profiles. For example, female patients have a higher risk of severe adverse events with 5-fluorouracil treatment. Understanding how gender influences treatment response is critical for optimizing colorectal cancer care. This interview took place at the European Society for Medical Oncology (ESMO) 2024 Congress in Barcelona, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.